Q3 2024 · 13F-HR
Deep Track Capital, LPholdings as filed
Filed 2024-11-14 · accession 0001856083-24-000007
$3.15B
Reported value
71
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 04016X101 | ARGX | ARGENX SE | $197.9M | 6.28% | 365,000 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $139.5M | 4.43% | 12,526,486 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $137.7M | 4.37% | 6,000,560 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $126.9M | 4.03% | 4,400,654 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $123.9M | 3.93% | 4,347,464 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $123.2M | 3.91% | 3,843,900 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $117.9M | 3.74% | 3,282,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $117.1M | 3.72% | 1,600,693 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $110.7M | 3.51% | 12,721,460 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $101.7M | 3.23% | 4,950,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $98.0M | 3.11% | 3,500,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $91.5M | 2.90% | 3,180,025 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $88.1M | 2.80% | 2,200,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $86.9M | 2.76% | 3,868,104 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $85.3M | 2.71% | 3,750,945 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $80.3M | 2.55% | 3,548,001 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $78.4M | 2.49% | 3,018,935 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $77.0M | 2.44% | 857,219 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $66.9M | 2.12% | 5,972,257 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $58.7M | 1.86% | 1,000,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $55.4M | 1.76% | 15,272,172 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $53.6M | 1.70% | 1,220,508 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $47.8M | 1.51% | 4,000,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $46.5M | 1.48% | 5,576,558 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $44.3M | 1.40% | 4,096,452 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $41.2M | 1.31% | 3,579,209 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $40.3M | 1.28% | 1,725,000 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $40.2M | 1.28% | 7,065,099 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $38.4M | 1.22% | 1,963,505 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $34.4M | 1.09% | 7,575,049 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $33.3M | 1.05% | 629,906 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $30.3M | 0.96% | 1,235,187 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $30.1M | 0.96% | 504,828 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $29.4M | 0.93% | 1,000,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $29.4M | 0.93% | 1,100,536 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $28.4M | 0.90% | 600,326 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $28.4M | 0.90% | 850,000 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $21.8M | 0.69% | 475,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $21.6M | 0.68% | 1,350,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $21.6M | 0.68% | 4,631,998 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $20.7M | 0.66% | 15,922,655 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $20.5M | 0.65% | 2,766,512 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $20.3M | 0.64% | 796,852 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $19.8M | 0.63% | 689,784 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $19.5M | 0.62% | 5,572,607 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $18.2M | 0.58% | 1,000,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $18.0M | 0.57% | 200,000 | CALL | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $17.2M | 0.55% | 2,607,633 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $16.7M | 0.53% | 4,900,334 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $16.1M | 0.51% | 800,000 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $15.4M | 0.49% | 4,184,100 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $14.5M | 0.46% | 7,419,355 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $13.6M | 0.43% | 1,529,987 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $13.3M | 0.42% | 3,283,783 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $11.2M | 0.35% | 10,953,937 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $11.0M | 0.35% | 2,169,143 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $10.4M | 0.33% | 1,804,366 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $9.2M | 0.29% | 967,000 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $7.5M | 0.24% | 567,428 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $7.4M | 0.24% | 531,857 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $5.3M | 0.17% | 1,553,996 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $5.1M | 0.16% | 3,262,564 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $3.3M | 0.10% | 5,000,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $2.5M | 0.08% | 219,648 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $2.4M | 0.08% | 180,500 | CALL | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $2.3M | 0.07% | 140,000 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $2.2M | 0.07% | 674,833 | Common | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $2.1M | 0.07% | 244,110 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $1.8M | 0.06% | 828,485 | Common | SOLE |
| 59102M104 | MGX | METAGENOMI INC | $667,275 | 0.02% | 307,500 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $385,281 | 0.01% | 48,100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.